These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21259306)

  • 1. Augmented p-rep designs.
    Williams E; Piepho HP; Whitaker D
    Biom J; 2011 Feb; 53(1):19-27. PubMed ID: 21259306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of augmented p-rep designs in multi-environmental trials.
    Moehring J; Williams ER; Piepho HP
    Theor Appl Genet; 2014 May; 127(5):1049-60. PubMed ID: 24553963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of experimental designs for selection in breeding trials with nested treatment structure.
    Piepho HP; Williams ER
    Theor Appl Genet; 2006 Nov; 113(8):1505-13. PubMed ID: 17028902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal designs for empirical bayes estimators of individual linear and quadratic growth curves in linear mixed models.
    Candel MJ
    Stat Methods Med Res; 2009 Aug; 18(4):397-419. PubMed ID: 19036913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-optimal cohort designs for linear mixed-effects models.
    Tekle FB; Tan FE; Berger MP
    Stat Med; 2008 Jun; 27(14):2586-600. PubMed ID: 17726724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stochastically curtailed phase II clinical trials.
    Ayanlowo AO; Redden DT
    Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of crossover trials for absorbing binary endpoints.
    Nason M; Follmann D
    Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An algorithm for the design of group sequential triangular tests for single-arm clinical trials with a binary endpoint.
    McWilliams TP
    Stat Med; 2010 Nov; 29(27):2794-801. PubMed ID: 20860065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factorial and time course designs for cDNA microarray experiments.
    Glonek GF; Solomon PJ
    Biostatistics; 2004 Jan; 5(1):89-111. PubMed ID: 14744830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral headache research: methodologic considerations and research design alternatives.
    Hursey KG; Rains JC; Penzien DB; Nash JM; Nicholson RA
    Headache; 2005 May; 45(5):466-78. PubMed ID: 15953263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling and design of cross-over trials.
    Jones B; Donev AN
    Stat Med; 1996 Jul; 15(13):1435-46. PubMed ID: 8841653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family planning operations research in Africa: reviewing a decade of experience.
    Wawer MJ; McNamara R; McGinn T; Lauro D
    Stud Fam Plann; 1991; 22(5):279-93. PubMed ID: 1759274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantages and disadvantages of adaptive designs for clinical trials.
    Bauer P; Brannath W
    Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group.
    Gray R; Manola J; Saxman S; Wright J; Dutcher J; Atkins M; Carducci M; See W; Sweeney C; Liu G; Stein M; Dreicer R; Wilding G; DiPaola RS
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1966-9. PubMed ID: 16609005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative designs of phase II trials considering response and toxicity.
    Jin H
    Contemp Clin Trials; 2007 Jul; 28(4):525-31. PubMed ID: 17428744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On group sequential designs comparing two binomial proportions.
    Kepner JL
    J Biopharm Stat; 2010 Jan; 20(1):145-59. PubMed ID: 20077254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal plus one point designs for testing lack of fit for some sigmoid curve models.
    Su Y; Raghavarao D
    J Biopharm Stat; 2013 Mar; 23(2):281-93. PubMed ID: 23437939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing statistical precision, power, and robustness of alternative experimental designs for two color microarray platforms based on mixed effects models.
    Tempelman RJ
    Vet Immunol Immunopathol; 2005 May; 105(3-4):175-86. PubMed ID: 15808299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.